📄 Redirect examination of Dr. Bruce Weir (1 of 2) — Thursday, June 22, 1995
Address:
C:\DEPT103\CRIMINAL\1995\JUN\22\REDIRECT-EXAMINATION-OF-DR-BRU.DOC
TRIAL
▲ Day 101 of 167

Redirect examination of Dr. Bruce Weir (1 of 2)

Witness: Dr. Bruce Weir
Examiner: George Clarke
Called by: Prosecution • Date: Thursday, June 22, 1995 • Utterances: 486
Defense attorney Thompson cross-examines prosecution DNA statistics expert Dr. Bruce Weir on the methodology for computing mixture statistics on several blood stains. Thompson challenges the assumptions underlying Weir's approach — specifically the number of contributors and whether all alleles are observed — and argues the Defense's simpler summing method from the NRC report is equally valid. The exchange is highly technical but grows tense as Thompson attempts to show Weir's calculations are circular, built on assumptions that presuppose the prosecution's theory, while Weir pushes back sharply, at one point calling Thompson's characterization 'close to being dishonest.'
1 MR. THOMPSON:

Thank you, your Honor.

CROSS-EXAMINATION BY MR. THOMPSON

2 MR. THOMPSON:

Good morning, Dr. Weir.

3 DR. WEIR:

Good morning.

4 MR. THOMPSON:

Now, the section of the National Research Council report that we are talking about on page 59 has the following language. It says: "If a suspect's pattern is found within the mixed pattern, the appropriate frequency to assign to such a match is the sum of the frequencies of all genotypes that are contained within."

5 DR. WEIR:

Yes.

6 MR. THOMPSON:

Now, can you tell us, Dr. Weir, what is a genotype?

7 DR. WEIR:

Oh, a genotype is a description of the genes or the alleles of an individual.

8 MR. THOMPSON:

Of an individual?

9 DR. WEIR:

Yes.

10 MR. THOMPSON:

Not two individuals?

11 DR. WEIR:

In usual language, yes.

12 MR. THOMPSON:

And the term "Genotype" doesn't refer to the genetic characteristics of three individuals either, does it?

13 DR. WEIR:

Not generally, no.

14 MR. THOMPSON:

No. So the term "Genotype" refers to the genetic characteristics of a single individual; isn't that right?

15 DR. WEIR:

That's right, but of course the language of this report, if we stuck to that, that would make no sense, so I interpret "Genotypes" here to mean genotypes to the contributors of the mixed stain.

16 MR. THOMPSON:

All right.

17 DR. WEIR:

It would make no sense otherwise.

18 MR. THOMPSON:

But that is your interpretation; that is not what the National Research Council says, is it?

19 DR. WEIR:

The National Research Council is reporting mixtures. We couldn't do a mixture analysis ignoring the fact that it is a mixture, so I take this as just loose language.

20 MR. THOMPSON:

Could I have chart 410 placed on the elmo, please.

21 MR. THOMPSON:

Dr. Weir, I would like you to take a look at this chart that has previously been marked chart 410 that has been prepared by the Defense, and I think you will see on this chart there is a list of numbers that are summed.

22 DR. WEIR:

Yes.

23 MR. THOMPSON:

Can you tell me is each of those numbers the frequency of a genotype?

24 DR. WEIR:

Yes, I believe so.

25 MR. THOMPSON:

All right. Now, let's take a look at chart no. 409, please. Now, Dr. Weir, are you looking at chart 409 which was previously prepared by the Prosecution?

26 DR. WEIR:

Yes, I am.

27 MR. THOMPSON:

All right. Now, I would like you to look at this--the number that is listed under the column headed "Frequency," this number .15 percent.

28 DR. WEIR:

Yes.

29 MR. THOMPSON:

Dr. Weir, is that the frequency of a genotype?

30 DR. WEIR:

It is the frequency of genotypes of the contributors to the mixed stain.

31 MR. THOMPSON:

But it is not the frequency of a genotype is it?

32 DR. WEIR:

Certainly not. That would be quite inappropriate.

33 MR. THOMPSON:

And what it actually is, is the product of the frequencies of two genos, isn't it?

34 DR. WEIR:

Certainly, certainly.

35 MR. THOMPSON:

And the reason that that number is so small, that is the .15 percent, is that you have taken two--two numbers and multiplied them together, taken two percentages and multiplied them together to get a smaller percentage? Isn't what you have done?

36 DR. WEIR:

The frequency is the product, yes.

37 MR. THOMPSON:

All right. Now, does the National Research Council report say anything about taking the product of two frequencies before you sum up these--

38 DR. WEIR:

No, no, but that is implied by the language. The frequency of the genotypes couldn't mean anything else.

39 MR. THOMPSON:

So your conclusion is that it couldn't mean anything else? That is the way you read it?

40 DR. WEIR:

Certainly we are talking about a mixture. To talk about an analysis of a mixture ignoring the mixtures would make no sense and I don't believe that that was what was intended.

41 MR. THOMPSON:

Is that what you always believed--

42 DR. WEIR:

The--

43 MR. THOMPSON:

--the NRC report meant or is this a new interpretation you arrived at only recently?

44 DR. WEIR:

I had never thought about this until quite recently. I have always done it the correct way.

45 MR. THOMPSON:

Well, what perplexes me, Dr. Weir, is that you have prepared several different versions of a report in this case.

46 DR. WEIR:

Yes, I have, yes.

47 MR. CLARKE:

Excuse me. Argumentative, the form of the question.

48 THE COURT:

Overruled. Proceed.

49 MR. THOMPSON:

All right.

50 MR. THOMPSON:

We have one report from you that is co-authored with Mr. Buckleton?

51 DR. WEIR:

Dr. Buckleton.

52 MR. THOMPSON:

Dr. Buckleton. That is dated May 11th?

53 DR. WEIR:

Yes.

54 MR. THOMPSON:

And in the report with Dr. Buckleton you use likelihood ratios, a different kind of statistics--

55 DR. WEIR:

No, not a different kind of statistic.

56 MR. THOMPSON:

All right. Let me rephrase the question. You use likelihood ratios to provide a measure to the extent of which the evidence favors one scenario over another; is that correct?

57 DR. WEIR:

The complete analysis must be in that framework. Of course a part of that calculation is the part where we are discussing at this point. This is the first part and in the complete and appropriate analysis.

58 MR. THOMPSON:

All right. And then on May 31st you produced another report labeled a draft. This one single page authored by yourself; is that right?

59 DR. WEIR:

If you say, yes, uh-huh.

60 MR. THOMPSON:

All right. And this report also used likelihood ratios to characterize the value of mixtures?

61 DR. WEIR:

Oh, as does my current report. The phrasing is still there, but my current report is focusing on this component of the likelihood ratio.

62 MR. THOMPSON:

Uh-huh. And in fact the report says likelihood ratios are essential in interpreting the evidentiary value of mixed stains, doesn't it?

63 DR. WEIR:

Yes. That is true, yes, whether that is single or mixed and of course we have had them throughout this case. Every number that is on the board is in fact giving us a likelihood ratio. The numbers I have discussed this morning for the mixture stains are giving us likelihood ratios by inverting them.

64 MR. THOMPSON:

Likelihood ratios for distinguishing between what hypothesis, Dr. Weir?

65 DR. WEIR:

The hypothesis of the two contributors being known versus them both being unknown.

66 MR. THOMPSON:

Okay. Are you planning to tell the jury that those frequency numbers are in fact likelihood ratios?

67 DR. WEIR:

If I am asked and under oath I would have no choice but to say of course they are.

68 MR. THOMPSON:

Okay. Then there was another report that was produced just this week with the date of June 20th. Are you familiar with that? That was June 20th is actually Tuesday.

69 DR. WEIR:

Yes.

70 MR. THOMPSON:

All right.

71 (Discussion held off the record between Defense counsel.)
72 MR. THOMPSON:

There is a June 20th report. On Tuesday we got a report. This report also used likelihood ratios; is that right?

73 DR. WEIR:

Well, all the reports have likelihood ratio language in them. All the reports also calculate frequencies of multiple contributors to a mixed stain. I'm not sure I understand what the distinction is you are trying to make.

74 MR. THOMPSON:

Okay. And in the report of June 20th you are quite critical of the National Research Council's method for dealing with mixtures, are you not?

75 DR. WEIR:

If it was interpreted as a single mix, yes, a single contributor, I would be, yes.

76 MR. THOMPSON:

Right. In fact, I see the sentence that reads: "In particular the method of assigning frequencies for mixtures suggested by the NRC report ignores the type of the profile of the person or people of interest and therefore has no probative value." Do you remember that sentence being in your report?

77 DR. WEIR:

Yes, but that is a separate issue of course that is talking about the enumerator of the likelihood ratio and that criticism of course is still with us. The--I think we are trying to confuse two issues here. Whether or not we give likelihood ratios is in a sense immaterial, but if we were to, we are comparing frequencies under two scenarios. For example, contributors being known or not known. There are two things. I believe if you merely give the bottom line, you are leaving out the alternative, so regardless of how you calculate the bottom line.

78 MR. THOMPSON:

Right.

79 DR. WEIR:

Yeah.

80 MR. THOMPSON:

Isn't it true, Dr. Weir, that when you were criticizing the National Research Council report in your--in your June 20th report--

81 DR. WEIR:

Yes.

82 MR. THOMPSON:

--you were referring to the interpretation of the National Research Council method for mixtures that has been advocated by the Defense in this hearing?

83 DR. WEIR:

I don't think so. My criticisms are whether or not they--we are comparing frequencies under alternative scenarios.

84 MR. THOMPSON:

All right. And--

85 (Discussion held off the record between the Deputy District Attorneys.)
86 MR. THOMPSON:

Just one moment, your Honor.

87 (Discussion held off the record between Defense counsel.)
88 MR. THOMPSON:

Dr. Weir, could you pick up exhibit 408, which is your report of June 21st?

89 DR. WEIR:

Yes, I'm just--I'm just flicking through pages here. Maybe could you help me and refer me to the page.

90 MR. THOMPSON:

If you could direct--direct your attention to page 10.

91 DR. WEIR:

All right.

92 MR. THOMPSON:

The paragraph labeled "Mixed stains." And the--

93 (Discussion held off the record between Defense counsel.)
94 MR. THOMPSON:

Your Honor, do you have a copy of this?

95 THE COURT:

Yes, I do.

96 MR. THOMPSON:

Okay.

97 MR. THOMPSON:

Now, am I right that the third sentence of that paragraph reads: "Simply adding the frequencies of all possible contributors to the mixture (NRC 1992) Ignores the essential nature of a mixture"?

98 DR. WEIR:

That is what it says, right.

99 MR. THOMPSON:

Now, when you wrote this sentence you were assuming, were you not, that the NRC approach involved simply adding the frequency of all possible contributors to a mixture, weren't you?

100 DR. WEIR:

I think that sentence would--would criticize it if that was the intention. I think, though--

101 MR. THOMPSON:

But isn't it true that--

102 MR. CLARKE:

May the witness finish his answer, please?

103 THE COURT:

Yes.

104 DR. WEIR:

I think, on reflection, I was being unfair to the NRC. I don't believe they would have meant a single contributor. That would have made no sense.

105 MR. THOMPSON:

All right. And so the--the interpretation of the NRC report which is reflected in the report of June 21st is not the interpretation that you now would adopt? Is that what you are saying?

106 DR. WEIR:

We are getting hung up with words here. The correct interpretation of any evidentiary stain is to compare the frequencies and their alternative scenarios. It's simple in a single stain because the likely--the chance that the frequency of the stain under one scenario is just one, it is a hundred percent, so in essence the frequency is hidden from us. And then we calculate the frequency for the unknown and we don't run into any need to examine what we are doing. We can--we can and we have seen the possibility of sloppy thinking, because we have ignored the alternative. For the mixtures we need to consider both alternatives.

107 MR. THOMPSON:

Now--

108 DR. WEIR:

However, one of those alternatives involves multiple unknown contributors and there is only one possible way for calculating the frequency of multiple contributors, regardless of what the NRC said or meant to say or is purported to have said. It is not a question of interpretation. Finally, it is a question of how do you calculate the frequency of multiple contributors, and there is only one way to do that.

109 MR. THOMPSON:

And you are not relying on the NRC report for the basis for your methods in any case, are you?

110 DR. WEIR:

No. Correct.

111 MR. THOMPSON:

You said you were relying on an article published by our friend Ian Evett?

112 DR. WEIR:

That is my published reliance, although I'm relying on my own expertise.

113 MR. THOMPSON:

And when was this article by Dr. Evett and his colleagues published?

114 DR. WEIR:

1991.

115 MR. THOMPSON:

Wasn't it published in 1990?

116 DR. WEIR:

I thought it was `91. I may be wrong.

117 MR. THOMPSON:

My copy says 1990.

118 DR. WEIR:

I have misspoken.

119 MR. THOMPSON:

I am reading wrong. You are right, so 1991.

120 MR. THOMPSON:

When was the National Research Council published?

121 DR. WEIR:

The report was published in 1990. You have hit on the points. Here is a report which ignores the literature. It is amazing to me that in this and many other instances they have chosen to ignore the correct procedures. Why they didn't cite this paper, I don't know.

122 MR. THOMPSON:

Right. So the very paper on which you were relying was simply ignored by the National Research Council?

123 DR. WEIR:

The paper on which I have cited. I don't rely on that paper.

124 MR. THOMPSON:

All right. All right. Now, this paper by Dr. Evett, the method that it describes is for characterizing mixtures in situations where we know how many contributors there are, is it not?

125 DR. WEIR:

Yes. I think so. That is--well, I believe all the--all our calculations assume a number of contributors, yes.

126 MR. THOMPSON:

Right. Now, but in this case we cannot tell by looking at most of the mixtures how many contributors there are, can we?

127 DR. WEIR:

Oh, I think the evidence is overwhelming that there were two contributors when we have seven RFLP loci and seven PCR loci and I have at most four alleles. I can't imagine any other possible interpretation.

128 MR. THOMPSON:

So does this evidence tell you--can you tell just by looking at the genetic evidence the probability that it is two persons who contributed versus three?

129 DR. WEIR:

I wouldn't attach a probability to that, no.

130 MR. THOMPSON:

You could not attach a probability to it, could you?

131 DR. WEIR:

I'm not sure about that. I would work--yes, I could work out the probability of that event conditional on each of those two assumptions.

132 MR. THOMPSON:

Right. But in order to--in order for you to compute the probability of getting these mixtures, assuming that there are either two people or three people, you would have to make some assumptions about the a priori probability of there being two or three contributors, wouldn't you?

133 DR. WEIR:

No. Well, excuse me. To give a posterior probability of the time analysis, I think the analogy is flawed; however, it ignores what we have been doing throughout the whole trial for a single stain. We compute the frequency of single contributors because all the evidence suggests there is a single contributor. No one has ever suggested we should compute the evidence of a single stain as though there were multiple contributors. All the evidence suggests there are not multiple contributors. I find the argument somewhat vacuous.

134 MR. THOMPSON:

But the answer to the question I just asked you is yes, is it not?

135 DR. WEIR:

You need to rephrase the question.

136 MR. THOMPSON:

Okay. The question is, in order for you to compute the probability of getting these mixtures, assuming there are either two or three people, would you have to make some assumption about the prior probability of there being two or three people?

137 DR. WEIR:

So my answer is certainly no to that. Given--you read that again, you will see that is a conditional probability you have just asked me about.

138 MR. THOMPSON:

All right. Suppose I framed it as a posterior probability. In order to get the posterior probability being two people versus three people--by posterior probability we mean the ultimate issue of there being two or three--we have to make some assumptions about the likelihood there are two or three there initially before we look at the evidence?

139 DR. WEIR:

We are not making posterior probabilities about anything in this trial, single stains or mixture stains or any other issue before us. We have no priors to put in to end up with posteriors.

140 MR. THOMPSON:

When you say the evidence is overwhelmingly in favor of there being two contributors to a stain--

141 DR. WEIR:

Yes, there is. There are seven RFLP loci, each of which has at most four alleles. There are seven PCR loci--well, depending on the stain--each of which has at most four alleles. How could it possibly be three contributors? It is beyond imagination.

142 MR. THOMPSON:

But in order to draw conclusions about the relative likelihood, you have to make some assumptions drawing on other evidence, don't you?

143 DR. WEIR:

The assumption I choose to do these frequencies is that there are either two or three contributors based on the evidence. There are two contributors. I have chosen to do it for three. I could have done it for four. I see no point.

144 MR. THOMPSON:

What about stain no. 29 where we are talking about the stain on the steering wheel?

145 DR. WEIR:

Uh-huh.

146 MR. THOMPSON:

Can you tell by looking at that stain whether there are two or three contributors?

147 DR. WEIR:

I can see no evidence there which suggests three, but you will need to give me some time to look at the RFLPs. They are there. So we have only the PCRs and there are three alleles at all those loci. That is six loci. Excuse me. Six loci have three alleles. There is nothing there which would suggest three contributors.

148 MR. THOMPSON:

Let's assume--let's assume there was no RFLP results on stain no. 29.

149 DR. WEIR:

Well, that is what the chart says.

150 MR. THOMPSON:

All right. And we see alleles.

151 DR. WEIR:

Yes.

152 MR. THOMPSON:

All right. And you say--but you can't determine, based on those three alleles, whether there are two people or three people there, can you?

153 DR. WEIR:

That is--that is a foolish question in the sense that the evidence--

154 MR. THOMPSON:

Will you answer it, please, sir.

155 THE COURT:

Wait, wait, wait, wait. Counsel, he gets to answer the question.

156 MR. THOMPSON:

All right.

157 DR. WEIR:

There are three alleles. We know that each person has two. People may share an allele, so two people may have two alleles, one of which is shared, which would end up with three. I can't imagine why you would invoke three people when there are only three alleles. There may be three people. There may be six people. There is nothing there which would require me to assume more than two.

158 MR. THOMPSON:

All right. And so based on the genetic evidence alone there is no basis for determining whether there is two or three or four?

159 DR. WEIR:

The evidence is that there are only at most four with here only three alleles. The polymarker had four--I think--I would have to look. I think only three alleles. So the evidence says there are three alleles. That means more than one person. It does not say anything about there being three people.

160 MR. THOMPSON:

Uh-huh. And so you can't tell whether there are two versus three based on this evidence alone?

161 DR. WEIR:

I can't tell for certainly.

162 THE COURT:

All right. Mr. Thompson, you have to understand I'm not making this determination in a vacuum. I assume that we have two victims at the crime scene. I'm taking into consideration that there appears to be only one set of footprints. I mean, this is not a determination made in a vacuum. Proceed. Proceed.

163 MR. THOMPSON:

All right. Just one moment.

164 (Discussion held off the record between Defense counsel.)
165 MR. THOMPSON:

Now, Dr. Weir, the Defense in this case has taken the position that numbers need to be presented to characterize the value of evidence showing consistency between the DNA profile of an individual and a mixed stain. Do you agree that numbers are necessary to show the value of such evidence?

166 DR. WEIR:

My opinion has changed. I think if you had asked me two years ago, I would have agreed. We are now at the point that the numbers are beyond belief. We have got so much genetic evidence, there are so many loci types, some of these items have 11 RFLP loci and 7 PCR loci. There is no number that makes any sense, that is beyond the belief--beyond the experience of anyone to try and interpret. I believe we have passed beyond the point where we should run around trying to make up numbers acceptable to everybody. The evidence of a match at this many loci is compelling, so I think once when we got to the point we are presently at, 7 RFLP loci, 7 PCR loci, the numbers are not necessary.

KEY QUOTE
167 MR. THOMPSON:

What about for evidence like that on item 29? Would the comments you just made apply to that stain as well?

168 DR. WEIR:

Well, my comments apply to seven of each type. On item 29 there are many fewer loci scored.

169 MR. THOMPSON:

Yes.

170 DR. WEIR:

The events of a match is not so astonishing and it is indeed helpful to have a number.

171 MR. THOMPSON:

And so I believe the intention of the Prosecutors initially was to present no number in connection with the mixed stains but merely to present the profile frequencies of individuals who were being compared to the stain. Would you agree with me that that would be a misleading procedure for characterizing the value of stains like no. 29, 305 and the other Bronco stains?

172 DR. WEIR:

Well, that is--I would need to examine each item separately. It would depend on the number of the loci.

173 MR. THOMPSON:

Let's start with no. 29 then. Do you think it would be misleading just to present the individual profile of individuals being compared to the stains, such as Nicole Brown Simpson, and not compute a special number that refers to the likelihood of her matching with the mixtures?

174 MR. CLARKE:

Objection, irrelevant.

175 THE COURT:

Overruled.

176 DR. WEIR:

It is not misleading, no. The evidence remains that there was a match between the evidence and known sample. That is not misleading to say that.

177 MR. THOMPSON:

Well--

178 DR. WEIR:

It is helpful to interpret that evidence to attach numbers under alternative scenarios.

179 MR. THOMPSON:

Uh-huh, but the question is would it be misleading to present just Nicole Brown's individual profile frequency and not do some computation regarding the likelihood of her matching a mixture?

180 DR. WEIR:

That is not the question you asked me. I don't know why we are computing Nicole Brown's profile frequency. Why are we doing that?

181 MR. THOMPSON:

Well, let me ask you the question this way: Would it be misleading to do what the Prosecutors were initially advocating in this case, which is to present no number on the mixture, per se, but just to present the profile frequencies of individuals who were being compared to the mixture? Would that be misleading?

182 MR. CLARKE:

Objection, irrelevant, also assumes facts not in evidence.

183 THE COURT:

Overruled.

184 DR. WEIR:

I don't know how to answer that. I'm not--I don't understand the question. Umm--there was a mixture. You either attach a number to it or you don't, but there was the evidence of a mixture. You either attach a number or not. It is not misleading not to attach a number. It is helpful to attach a number. Calculating one of the--one of the matching known frequencies is beside the point. It has nothing to do with the mixture, so I don't understand.

185 MR. THOMPSON:

Well, let's suppose that the frequency of Nicole Brown's DNA profile on DQ-Alpha and the polymarker systems ranged from 1 in 2500 to 1 in 26,000. Do you understand that assumption, a relatively rare profile across--across DQ-Alpha and the polymarker loci?

186 DR. WEIR:

The frequency of people who would match that profile?

187 MR. THOMPSON:

Yes.

188 DR. WEIR:

That that is a range of numbers?

189 MR. THOMPSON:

Right. Do you think it would be misleading for the Prosecutors to give a number like 1 in 26,000 to Nicole Brown's profile and then to say through testimony that Nicole Brown Simpson's profile is consistent with stain 29 and give no further number?

190 DR. WEIR:

That doesn't--that doesn't tell all the information, I agree, yes.

191 MR. THOMPSON:

So you agree that that would be misleading?

192 DR. WEIR:

I'm not sure I would say misleading. It doesn't--it reflects a fallacy of trying to give any of this evidence outside the appropriate framework. Unless you give frequencies attached to items of evidence, and their alternative scenarios, you cannot make a determination which in fact was the most likely scenario. So anytime you try and concoct these methods of presenting evidence outside the appropriate way of doing it, you will run into problems. I mean, you or anybody.

193 MR. THOMPSON:

Uh-huh. And by your calculations, the probability that two randomly chosen individuals, one Caucasian and one African American, would--would match with stain no. 29 is 1 in 71; isn't that right.

194 DR. WEIR:

That's true?

195 MR. THOMPSON:

Right? Which is considerably higher than Nicole Brown Simpson's profile frequency, isn't it?

196 DR. WEIR:

Yes.

197 MR. THOMPSON:

All right. All right. And so it would be incorrect, wouldn't it, to use Nicole Brown's profile frequency as an index of the value of the fact that she was consistent with that stain, wouldn't it?

198 DR. WEIR:

If you state it like that, that sounds incorrect to me, yes.

199 MR. THOMPSON:

All right. Okay. Now, so it sounds like the real--the real issue here is over methods for doing these mixture calculations; isn't that--and we basically agree a number is needed to characterize a mixture, and our disagreement is how to compute that?

200 DR. WEIR:

We haven't agreed that the number is needed, no.

201 MR. THOMPSON:

Okay. All right. Would you agree, Dr. Weir, that in order to do the kind of calculations that you are doing on the exhibit currently on the elmo, which I believe is no. 410--

202 THE COURT:

F09.

203 MR. THOMPSON:

409. In order to do the calculations on chart 409, you need to make certain assumptions?

204 DR. WEIR:

Yes.

205 MR. THOMPSON:

And one assumption you need to make is with regard to the number of contributors to the stain?

206 DR. WEIR:

Yes.

207 MR. THOMPSON:

Now, does that assumption, with regard to the number of contributors, does that assumption have to be made to do the calculations in the manner reflected on chart 410, which is the Defense's approach to the calculation?

208 DR. WEIR:

It doesn't, but that is not a relevant fact. We have no choice. It is not a question of taste or opinion. If we want to estimate the frequency of the contributors to the mixture, we must take account of the number of contributors. I'm not sure how I can say that any more simply. It is not rocket science here.

209 MR. THOMPSON:

Now, another assumption that your approach makes is that all alleles of all contributors can be detected; is that correct?

210 DR. WEIR:

That's true. I have had to assume that I am not an expert in the molecular biology. I take what the forensic scientists approach.

211 MR. THOMPSON:

Does that assumption need to be made to make the calculations reported by the NRC counsel I'm chart?

212 DR. WEIR:

Absolutely. You can't do anything until you have a starting point which is at least found. Now, I will continue, because there are cases where we know there were two contributors, but we see less than four alleles at a locus. It shows up more clearly in the RFLP situation where some of the alleles appear either or hidden or to be not seen.

213 MR. THOMPSON:

Let me direct your attention again to chart number--excuse me, is this 409?

214 THE COURT:

This is 410.

215 MR. THOMPSON:

410, the Defense chart 410.

216 MR. THOMPSON:

Now, based on the calculations done on this chart, Dr. Weir, would it be correct to say among Caucasians the percentage of people who have genotypes consistent with alleles observed in stain 29 is approximately 45 percent?

217 DR. WEIR:

That is a completely misleading statement and I don't even believe it is true. "Consistent" means you can account for the stain with the people listed. You cannot account for the stain by adding up those single contributors. The first item does not account for alleles 1.2 and 4. If you--that statement you made, and I listened very carefully, I think comes very close to being dishonest.

218 MR. THOMPSON:

Is it--is it incorrect scientifically, doctor?

219 DR. WEIR:

Yes, it is incorrect scientifically because it is not--I take "Consistent" to mean explaining the data.

220 MR. THOMPSON:

All right. Let's--let's instead ask the question this way: Would it be correct to say that among Caucasians the percentage of people who have genotypes that would be included in the stain observed in stain 29--included in the alleles observed in stain 29 is approximately--let me--let me start again. Based on this chart, no. 410, would it be correct to say that among Caucasians the percentage of people who have genotypes that would be included in the set of alleles observed in stain 29 is approximately 45 percent?

221 DR. WEIR:

That statement is correct, but it is misleading in the sense it gives us no basis for interpreting the evidentiary value of this mixed stain. It is a correct statement, but I don't think it has any relevance.

KEY QUOTE
222 MR. THOMPSON:

So it is scientifically correct, but it is misleading? Is that your position?

223 DR. WEIR:

Absolutely.

224 MR. THOMPSON:

Now, when you say "Misleading," what you mean, I take it, is that you think it might give the jurors the wrong idea about how to think about this evidence?

225 DR. WEIR:

I mean it is misleading in that it gives us no basis for interpreting the evidence of matching between known contributors and a mixed stain. It gives us no foundation to making--drawing any conclusions numerically.

226 MR. THOMPSON:

Well, suppose that I, upon learning that Nicole Brown Simpson's genotypes are consistent with those found in stain no. 29, was curious to know what percentage of people in the population have genotypes consistent with those in stain 29. Isn't 45 percent the number that I need to know to respond to that--

227 DR. WEIR:

You might want to know that, but that is not a question that we would need to be addressing here. It is not relevant. I mean that is an interesting question, I suppose, but why would you even ask it? The evidence is that there are two known contributors. They match the mixed stain. Is that--how often does that happen coincidentally?

228 MR. THOMPSON:

All right. So your argument--

229 DR. WEIR:

If you want to talk about Nicole Simpson, you need to consider the scenario of Nicole Simpson versus another unknown versus two unknowns.

230 MR. THOMPSON:

Okay. So if I understand your argument correctly, you are arguing that the way the jury should think about the problem or the way anyone else should think about the problem is in terms of the likelihood of getting a pair of individuals that would match rather than just a single individual who would match? Is that your position?

231 DR. WEIR:

Yes, I've been saying that for the last two hours.

232 MR. THOMPSON:

All right. But, doctor, isn't that just an argument you are making?

233 DR. WEIR:

Excuse me. I recent that completely. That is not just an argument. That is the only conceivable way of attaching a frequency to the match of two known contributors in a mixed stain. How could you possibly do anything else? And to characterize it as just an argument I think is unfortunate.

234 (Discussion held off the record between Defense counsel.)
235 MR. THOMPSON:

Doctor, you keep using this phrase "Known contributors," as in two known contributors.

236 DR. WEIR:

Yes, I'm talking about the people not excluded. The people whose profiles we know.

237 MR. THOMPSON:

All right. But we don't--we don't know who the contributors are of any stains in this case based on the genetic evidence alone, do we?

238 DR. WEIR:

The known samples, yes.

239 MR. THOMPSON:

All right. So those are assumptions? All right.

240 DR. WEIR:

Well, that is what we have to--what the jury eventually will have to decide, are these two known people the contributors or are two other people so we are comparing those two known people with two unknown people. So that is not an assumption; that is what the trial is about, to make decisions on the origins of these stains.

241 MR. THOMPSON:

All right. To answer questions about the number of people in the population or in some population that would have genotypes that would be included in a mixture, such as no. 29, is it necessary to make assumptions about whether all alleles of all contributors to the mixture have been observed?

242 THE COURT:

I thought we asked that question already.

243 DR. WEIR:

I have answered and on the RFLPs we don't--we--my calculations show that we allow for unseen bands.

244 MR. THOMPSON:

Well, what about--let me restate the question and I believe it is a different question this time, your Honor.

245 MR. THOMPSON:

If--if the question that I want to have answered is--is what percentage of the population would have genotypes consistent with the observed alleles, isn't it true that I don't have to make any assumptions at all about whether all alleles of all contributors have been observed?

246 DR. WEIR:

I think I understand the question. The answer is yes and that is what I have done. My calculations assume these are the only alleles in the--in the mixed stain.

247 MR. THOMPSON:

All right. So--

248 DR. WEIR:

For the PCR.

249 MR. THOMPSON:

But to do it--to do it the way reflected on the Defense chart where you are simply summing, and--and asking the question what percentage of the population has genotypes consistent with the observed alleles, we need make no assumption about whether all alleles have been observed; isn't that correct?

250 DR. WEIR:

You don't need to make any assumptions but then you don't end up with a meaningful answer.

251 MR. THOMPSON:

Right. Whereas under your approach assumptions do need to be made about whether or not all alleles of all contributors have been observed?

252 DR. WEIR:

That is correct for the mixture and the single stains, is that the foundation of the whole forensic uses of DNA we have alleles seen, we calculate frequencies for them. If one was to object that that assumption, one might as well hang up their hat and go home because none of this would be possible. Of course we assume the number of contributors is consistent with the evidence.

253 MR. THOMPSON:

Okay.

254 DR. WEIR:

Either one or two or however many.

255 MR. THOMPSON:

Okay. So there are two assumptions that are being made under your approach which need not be made--

256 DR. WEIR:

I object to you characterizing it as my approach.

257 MR. THOMPSON:

Under the approach that you have presented in your report.

258 DR. WEIR:

Thank you.

259 MR. THOMPSON:

There are two assumptions being made there that need not be made to use the kind of numbers that are presented in the Defense chart, one being the number of contributors and the other being the connection between the observed alleles and the contributor's allele?

260 DR. WEIR:

For both mixed and single stains, yes.

261 MR. THOMPSON:

Yes. Okay. Now, doctor your expertise is in drawing statistical inferences from genetic data; is that correct?

262 DR. WEIR:

Yes.

263 MR. THOMPSON:

One of the issues that statisticians like yourself are most concerned with is what is and isn't a logical from a scientific finding?

264 DR. WEIR:

Yes.

265 MR. THOMPSON:

And I often hear statisticians use the term "Permissible" as in this is a permissible--

266 DR. WEIR:

Excuse me, I didn't hear the word.

267 MR. THOMPSON:

Permissible, as in this is a permissible inference or this is not a permissible inference. Is that a common expression in your field?

268 DR. WEIR:

It is not one I have heard before.

269 MR. THOMPSON:

Oh, okay. What expression would you use to talk about an inference which is illogical and inappropriate?

270 DR. WEIR:

I call it wrong, I suppose.

271 MR. THOMPSON:

Wrong. Okay. Now, I gather when statisticians say an inference is wrong, it means it is illogical or fails to follow from the premises?

272 DR. WEIR:

I imagine they would, yes.

273 MR. THOMPSON:

Okay. And the question about which inferences are correct and incorrect, wrong or right, when interpreting scientific data, is one of the major questions that statisticians concern themselves with?

274 DR. WEIR:

I don't see statistics as being consumed with giving right or wrong answers. Statistics is concerned with teasing out the information and sets of data, how results are often traced in terms of estimates or results of hypothesis testing. Statistics is not a black and white, right or wrong, yes or no kind of a science. It is a science of interpreting data, so I'm having trouble with understanding your characterization of statistics.

275 MR. THOMPSON:

But part of what statisticians do is determine what is and what is not a reasonable statistical inference from data; isn't that correct?

276 THE COURT:

Counsel, the issue is which of these two methodologies am I going to adopt for use in front of this jury.

277 MR. THOMPSON:

Uh-huh.

278 THE COURT:

Which makes sense both in terms of the science that produces these results and the math that is applied to it.

279 MR. THOMPSON:

Yeah.

280 THE COURT:

So--

281 MR. THOMPSON:

These questions are foundational to my next line.

282 THE COURT:

Well--

283 MR. THOMPSON:

I will proceed quickly.

284 MR. THOMPSON:

Dr. Weir, when drawing conclusions from a scientific tests, should an expert witness in a criminal case rely only on the scientific data or is it permissible for the expert to take into account other evidence in the case?

285 DR. WEIR:

These--this is such a general question I don't understand it. I will say yes, but I'm not fully understanding what you are meaning.

286 MR. THOMPSON:

Well, suppose, for example, that an expert sees a scientific test result that has two possible interpretations and one interpretation is consistent with guilt and the other interpretation is consistent with innocence. Would it be permissible for the expert to consider the overall strength of the Prosecution's case when deciding which scientific interpretation was correct?

287 MR. CLARKE:

Objection, irrelevant to this hearing.

288 THE COURT:

Sustained.

289 MR. THOMPSON:

Would it be permissible for a statistician, in determining which statistical procedure is appropriate or inappropriate, to take into account the strength of the Prosecution's case?

290 MR. CLARKE:

Same objection.

291 THE COURT:

Sustained.

292 MR. THOMPSON:

Dr. Weir, have you heard the term "Bootstrapping" when that term is used to refer to allowing one set of evidence to influence a supposedly independent judgment?

293 MR. CLARKE:

Same objection.

294 THE COURT:

Sustained.

295 (Discussion held off the record between Defense counsel.)
296 MR. THOMPSON:

Now. Yeah. Have you heard the term "Bootstrapping" used in the scientific arena, as opposed to the legal arena?

297 MR. CLARKE:

Same objection.

298 THE COURT:

Overruled.

299 DR. WEIR:

The word "Bootstrapping" is in my report.

300 MR. THOMPSON:

Right. Now, I know your report refers to a statistical procedure known as bootstrapping. Have you heard an additional meaning of that term "Bootstrapping" in scientific circles?

301 DR. WEIR:

No.

302 MR. THOMPSON:

Meaning to draw--draw conclusions on--on--

303 THE COURT:

Counsel, this is not real helpful to me.

304 MR. THOMPSON:

Well, I--

305 THE COURT:

It is really not. It is a complete waste of my time so far, this whole discussion about bootstrapping.

KEY QUOTE
306 MR. THOMPSON:

I was. I think I can tie it in, your Honor, if you will give me some leeway.

307 THE COURT:

No.

308 MR. THOMPSON:

All right.

309 THE COURT:

Proceed.

310 MR. THOMPSON:

Now, Dr. Weir, in order to compute the mixture statistics using your method--

311 DR. WEIR:

And it is not my method.

312 MR. THOMPSON:

Well, using the method that you are advocating, you need to make assumptions, and would you agree with me that the numbers that are produced by your method vary depending on the assumptions that you make?

313 DR. WEIR:

You will have to be specific. I don't know what you mean.

314 MR. THOMPSON:

For example, the numbers that you produce would vary depending on whether you assume there were two contributors or three contributors?

315 DR. WEIR:

My report shows two tables with different numbers under those two conditions.

316 MR. THOMPSON:

So--

317 DR. WEIR:

I also have tables for single stains where I have assumed a single contributor. I have answered that several times.

318 MR. THOMPSON:

And so the answer is yes?

319 DR. WEIR:

Yes.

320 MR. THOMPSON:

All right. And the numbers that you compute would also vary, depending on whether you assumed that all alleles of all contributors are being observed in the stain?

321 DR. WEIR:

The answers of all the analyses in this trial depend on that assumption.

322 MR. THOMPSON:

Okay. And so under some assumptions you get numbers that are much bigger and more impressive than under other assumptions, don't you?

323 DR. WEIR:

I don't understand the question. You will need to be specific.

324 MR. THOMPSON:

And have you noticed, Dr. Weir, that when you compute numbers under assumptions that are consistent with the Prosecution's theory of the case that you will get numbers that are larger and more supportive of the Prosecution's case?

325 MR. CLARKE:

Objection, argumentative and also irrelevant.

326 THE COURT:

Sustained.

327 MR. THOMPSON:

Is it the case, Dr. Weir, that if you compute numbers under assumptions consistent with the Prosecution's theory of the case, that the numbers that are produced by the method you are advocating are more supportive of the Prosecution's theory of the case?

328 MR. CLARKE:

Same objection.

329 THE COURT:

Sustained.

330 (Discussion held off the record between Defense counsel.)
331 THE COURT:

Mr. Thompson, if it is of any benefit to you, I understand the two assumptions that underlie Dr. Weir's testimony and the calculations that he makes and the fact that you will get different results depending on what the assumptions are. I understand that. I understood that an hour ago.

332 MR. THOMPSON:

Okay. All right.

333 MR. THOMPSON:

Let me ask you a few questions, Dr. Weir, about what your report says concerning item no. 78, and I think if you look--if you look in your report at page 25--

334 DR. WEIR:

Thank you.

335 THE COURT:

Refresh my recollection. Which item was item no. 78?

336 MR. THOMPSON:

Item 78 was a stain on the bottom of Ronald Goldman's boot.

337 THE COURT:

On the bottom of the sole of his boot.

338 MR. THOMPSON:

It contained a number of alleles which were consistent with Nicole Brown Simpson on RFLP tests, along with a few that were consistent with Ronald Goldman.

339 MR. THOMPSON:

Is that a correct characterization, sir?

340 DR. WEIR:

Excuse me. Did you ask a question?

341 MR. THOMPSON:

Yeah. I was asking you if it is correct to say that item 78, the stain on Mr. Goldman's boot, contains a number of alleles consistent with Nicole Brown Simpson together with a few that are consistent with Ronald Goldman?

342 DR. WEIR:

Yes. If we use the word "Match" I think would be a better word.

343 MR. THOMPSON:

Okay. Mr. Goldman also has a few alleles that are not observed in item 78; is that correct?

344 DR. WEIR:

Yes. This is an MS43 allele not in the mixture and two YNH24 alleles in Goldman's profile not in the mixture.

345 MR. THOMPSON:

Now, I see in your report on page 7 that you say Ronald Goldman is not excluded from that stain?

346 DR. WEIR:

That's correct.

347 MR. THOMPSON:

Okay. All right. But Ronald Goldman does have some alleles that are not in the stain, doesn't he?

348 DR. WEIR:

Well, now you are getting into an item which is beyond my expertise and I believe we've had testimony from Cellmark as to the reason they call the matches and non-matches and exclusions. My analysis must start with the forensic scientist's determination and they said there was a failure to exclude based on the molecular biology and the description of the staining patterns which is beyond my expertise to interpret. I will accept their interpretation. I can't do anything unless I have a starting point. The starting point is the determination made by the forensic scientist. Given that starting point, my analysis follows. So whether or not alleles match or not, are found are not, that is where I start.

349 MR. THOMPSON:

Okay. Well, let's start--let's start with your chart on page 25. Would you degree with me that your chart shows Ronald Goldman having some alleles that are not observed in item 78?

350 DR. WEIR:

That's true.

351 MR. THOMPSON:

So would you agree that Cellmark must have assumed that some alleles of some contributors at some loci to item 78 were not observed?

352 DR. WEIR:

I--

353 MR. CLARKE:

Objection, irrelevant.

354 THE COURT:

Overruled.

355 DR. WEIR:

I think I have already said that. My starting point is the determination of non-exclusion. All these other things will follow from that.

356 MR. THOMPSON:

Okay. So this is one of those cases where assumptions about whether all alleles have been observed come into play? Would you agree?

357 DR. WEIR:

I have said that several times repeatedly and I'm going to say it again. Maybe we could start the question. I'm going to take the determination by Cellmark that there were two contributors, neither brown nor Goldman are excluded, and my calculations will proceed from that point. All these other things are details of that statement.

358 MR. THOMPSON:

Now, did you make--when you were doing computations for item 78, did you make the same assumptions with regard to alleles showing up in making your statistical computations that Cellmark made when determining the match?

359 DR. WEIR:

I don't know how else I can say it, I'm sorry. That was the same question as before. Cellmark has determined a match, they have not excluded two people. I start from that and proceed. I don't know how else I'm going to say it.

360 MR. THOMPSON:

All right. And would that--does that mean then, that on those loci where Mr. Goldman's alleles do not show up in the mixtures, you assumed there were missing alleles?

361 DR. WEIR:

That and every other detail. I don't know how else I can say it.

362 MR. THOMPSON:

And on those loci where Mr. Goldman's alleles or those matching--alleles matching Mr. Goldman were found, you assumed there were no missing alleles, didn't you?

363 DR. WEIR:

My assumptions are that Cellmark has declared a match with these two stains, not excluded people. The bands showing in Goldman I'm going to use in my analysis, whether or not they show in the mixtures, because he has not been excluded from the mixture.

364 MR. THOMPSON:

So whether or not you assumed they were missing alleles at a particular locus--

365 DR. WEIR:

I haven't assumed anything. I am taking the analysis presented me from Cellmark.

366 MR. THOMPSON:

Well--

367 DR. WEIR:

The analysis is that there was a mixture consistent with these contributors, Goldman's bands are not showing in the mixture YNH24. That is not my assumption. That is what Cellmark told me their determination was. My analysis reflects that determination. I assume nothing.

368 MR. THOMPSON:

So, for example, on locus G3 you are proceeding, or your analysis proceeds from the premise that there are unseen alleles in the mixture, that there are--not all--not all alleles of all contributors are seen in the mixture, aren't you?

369 DR. WEIR:

I'm still going to say, yes, it is the same question.

370 MR. THOMPSON:

But you are not making that assumption when analyzing locus MS1, aren't you?

371 MR. CLARKE:

Asked and answered.

372 THE COURT:

Overruled.

373 DR. WEIR:

There is no need to. Under the scenario of known contributors we have all bands accounted for. Under the scenario of unknown contributors, we need to work with the four unknowns. We need to look at this entire package. The package is consistent with there being two contributors. I have therefore conducted an analysis on the basis of there being two unknown contributors, which would result in those four alleles at MS1.

374 MR. THOMPSON:

So you made that--you made the assumption of unseen alleles where that was necessary and you didn't make it where it was unnecessary; is that right?

375 DR. WEIR:

I haven't assumed unseen alleles. I say there are alleles I have seen. I'm going to assume there were two contributors. I'm going to compute from two contributors.

376 MR. THOMPSON:

Whether your calculations proceeded on the basis that there were missing alleles or not at a particular locus depended entirely on whether that assumption was necessary to make Mr. Goldman match; isn't that true?

377 DR. WEIR:

I don't believe so. My calculations are for two unknown contributors.

378 MR. THOMPSON:

What is your--

379 DR. WEIR:

My calculations have nothing to do with matching. That is the top line of the likelihood ratio. I'm doing two unknown contributors. Two unknown contributors. How do two unknown contributors give those two alleles?

380 MR. THOMPSON:

What is your independent scientific basis for assuming that there were missing alleles at YNH24, for example, but not at MS1?

381 MR. CLARKE:

Objection, asked and answered.

382 THE COURT:

Overruled.

383 DR. WEIR:

I have no outside evidence other than what Cellmark told me. All of my analyses are based on what the forensic scientists have told me. If they told me this, then I will proceed accordingly. It is beyond my expertise to do otherwise.

384 MR. THOMPSON:

And had they assumed--had they made the opposite assumption, for example, assuming there were missing alleles at MS1, but not at YNH24, Mr. Goldman would have been excluded, wouldn't he?

385 MR. CLARKE:

Objection, irrelevant to this hearing.

386 THE COURT:

Sustained.

387 MR. THOMPSON:

Dr. Weir, isn't your logic in drawing conclusions from item 78 circular, in that you are basing your conclusions on premises that are consistent with the Prosecution's theory of the case?

388 DR. WEIR:

Not--

389 THE COURT:

Sustained.

390 MR. THOMPSON:

Now, Dr. Weir, in your report you mention hypotheses that can be tested by the data and you label them c and c prime. Is it called c prime when you put--

391 DR. WEIR:

C--the word c is abbreviation for contact.

392 MR. THOMPSON:

Contact.

393 DR. WEIR:

Contact between the known person and the location of the evidentiary stain. We can say hypothesis or scenario. I'm not sure what the best word is. I think I would use them interchangeably.

394 MR. THOMPSON:

Okay. And so your report suggests that two hypothesis that are to be distinguished by the genetic data are contact and no contact?

395 DR. WEIR:

I think that is the best term, yes.

396 MR. THOMPSON:

All right. What is does the term "No contact" mean?

397 DR. WEIR:

How else can I say it? Not having had contact.

398 MR. THOMPSON:

Okay. And so, for example, with regard to stain 29, if we were interested in whether Nicole--Nicole Brown Simpson's blood was in that stain on the Bronco steering wheel, a no contact would mean known of her blood had gotten into the Bronco? Is that what--into that stain. Is that what that would mean?

399 DR. WEIR:

I'm not sure--I'm not sure. We need to be careful. The contact there would be between Nicole Brown Simpson and the steering wheel. Somehow under that scenario her blood went from her body to the steering wheel. That is contact. It not might not mean with her physical self, but some means of contacting her blood--contact of her blood with the steering wheel, whatever the agent was for making that contact.

400 MR. THOMPSON:

And--and are you--are you planning to testify that your frequencies represent the probability of this evidence under the assumption of no contact?

401 DR. WEIR:

All the numbers on this chart are frequencies and frequency and probability I use interchangeably. All these numbers we've held in the entire case are the probabilities of the evidence under the situation of no contact. In other words, a random person. Someone other than the known, than the stated person, having contributed that.

402 MR. THOMPSON:

Are you assuming, Dr. Weir, that a coincidental match is the only way in which the evidence we have observed can arise under the--under the hypothesis of no contact?

403 DR. WEIR:

I have not said that here or anywhere else, no.

404 MR. THOMPSON:

So you are assuming that there other ways that this evidence could arise that are not reflected in your numbers?

405 DR. WEIR:

I'm not assuming anything. I have made some calculations accounting for the evidentiary stains from unknown people. I'm saying nothing else.

406 MR. THOMPSON:

Well, you think these frequencies are basically likelihood ratios, don't you?

407 DR. WEIR:

A frequency is the frequency of the evidence given known or unknowns. If you start taking ratios of frequencies--I'm sorry if you don't like the term, but that ratio of frequencies is a likelihood ratio.

408 MR. THOMPSON:

And when you testify that there is--when you put a--when you testify that there is a 1 in 71 chance of observing the pair of contributors--a pair of contributors--well, there is a 1 in 71 chance that a pair of contributors at random could have left the stain on item 29--

409 DR. WEIR:

That is the Prosecutor's fallacy, Mr. Thompson. I am surprised at you.

410 MR. THOMPSON:

Ah, ah, forgive me. It is very easy to fall into.

411 DR. WEIR:

I don't believe it is easy for you to fall into that trap at all and I'm certainly not going to fall into it by you leading me into it.

412 MR. THOMPSON:

I was actually leading you into another trap, sir, but let me proceed. Well, you expressed the term--you used the frequency 1 in 71 in connection with the stain on the steering wheel of the Bronco. Could you explain just exactly what exactly that 1 in 71 means?

413 DR. WEIR:

That is the frequency or probability and I will use them interchangeably. That is the probability of seeing that mixed profile from two unknown contributors of specified ethnic origin.

414 MR. THOMPSON:

Okay. When you compute the probability of seeing that profile under the assumption of no contact, you are assuming that the only way we would see that profile under the assumption of no contact was a coincidental match, aren't you?

415 DR. WEIR:

I don't--don't think that is correct. I've calculated the frequency with which--of getting this profile from two unknown contributors. That actually doesn't say anything about contact or not. It is the contact refers of course to the known people, the people not excluded. You better restate your question I think.

416 MR. THOMPSON:

Well, well, I guess the trouble I'm having is with the two hypothesis of contact, no contact, and your assertion is that the--the statistics that you are presenting give us the conditional probability of this evidence under no contact, isn't that--

417 DR. WEIR:

No contact of the--of the not excluded people, yes.

418 MR. THOMPSON:

Okay. But we could get the observed evidence in a number of ways other than simply the ways taken into account in your frequency calculations, couldn't we?

419 DR. WEIR:

You will have to explain what alternatives you mean.

420 MR. THOMPSON:

Suppose there was tampering with the evidence, for example?

421 MR. CLARKE:

Objection, irrelevant.

422 THE COURT:

Overruled.

423 DR. WEIR:

I--I--I'm very, very careful at the first page of my report to say my entire analysis is concerned with the genetic statistics. It assumes matches when declared to be true. It assumes profiles when declared to be accurate. It is--it would be wrong of me to make statements outside that context.

424 MR. THOMPSON:

But if you are not taking into account anything other than coincidental match frequencies, isn't it also wrong to tell the jury that those frequencies characterize the probability of this evidence under the assumption of no contact?

425 DR. WEIR:

I don't believe so, no, not in the way--not--if--if we are careful, I have been careful in my writing, if we are carefully orally, I don't think there will be any confusion.

426 (Discussion held off the record between Defense counsel.)
427 MR. THOMPSON:

May I have one moment?

428 (Discussion held off the record between Defense counsel.)
429 MR. THOMPSON:

A few more questions.

430 MR. THOMPSON:

You mentioned in direct examination that you work as a consultant for Cellmark diagnostics?

431 DR. WEIR:

No. I said my university has a contract with Cellmark.

432 MR. THOMPSON:

Okay. Can you describe the nature that have contract?

433 DR. WEIR:

What do you mean?

434 MR. THOMPSON:

How much money does it involve?

435 DR. WEIR:

$8,000 a year.

436 MR. THOMPSON:

$8,000. And the money is granted to the university?

437 DR. WEIR:

The money is paid to the university.

438 MR. THOMPSON:

Is it put in a fund that is at your disposal?

439 DR. WEIR:

I wish.

440 MR. THOMPSON:

Who gets the money?

441 DR. WEIR:

The money goes to the Dean of Agriculture.

442 MR. THOMPSON:

Okay. Do you benefit personally from that in any way?

443 DR. WEIR:

No.

444 MR. THOMPSON:

You also said you are a consultant with a number of other forensic laboratories doing analysis of their databases?

445 DR. WEIR:

No, I didn't say that. If I did, I misspoke. We have similar contractual arrangements with other companies.

446 MR. THOMPSON:

Okay. Now, in all cases where you act as a consultant for these forensic labs, does the money flow to the university or does it flow to you?

447 DR. WEIR:

Under these contracts, the university gets the money, yes.

448 MR. THOMPSON:

Okay. Do you earn income personally for consulting with forensic laboratories?

449 DR. WEIR:

I have, yes, on occasion.

450 MR. THOMPSON:

Okay. Now, which laboratories have you been paid directly by?

451 DR. WEIR:

Received money from?

452 MR. THOMPSON:

Yes.

453 DR. WEIR:

Several state agencies. Not my own state. South Carolina, Minnesota. I'm hoping to get some money from Illinois, although it hasn't come yet. Broward County in Florida.

454 MR. THOMPSON:

Have you money directly from Cellmark under any other circumstances?

455 DR. WEIR:

No. I have visited Cellmark. I think they picked up the fare.

456 MR. THOMPSON:

What about genetic design?

457 DR. WEIR:

Genetic design we have a contractual arrangement. I think I've received a little money from them some years ago, but I'm not sure. Some of that was sort of--they were acting as a conduit from a third party. There may have been a little money from them a couple of years ago.

458 MR. THOMPSON:

Have you received any money from the FBI?

459 DR. WEIR:

No.

460 MR. THOMPSON:

Okay. Now, I see in your grant that you received a grant from the Department of Justice?

461 DR. WEIR:

We received--the university received a grant this year from NIJ, yes.

462 MR. THOMPSON:

What is the amount of that grant. $25,000.

463 MR. THOMPSON:

And do you receive any personal compensation from that grant?

464 DR. WEIR:

I think you know, Dr. Thompson, that would be quite illegal.

465 MR. THOMPSON:

For example, does it pick up summer salary?

466 DR. WEIR:

No. I have a twelve-month salary. I receive nothing directly or indirectly from that grant.

467 MR. THOMPSON:

Does it cover post-doc expenses or give you discretionary funds for your lab?

468 DR. WEIR:

It is contained, as you can see from the application, to compensate a person working for me on these issues.

469 MR. THOMPSON:

Okay. And was the FBI involved in helping you obtain that grant?

470 DR. WEIR:

I wouldn't think so.

471 MR. THOMPSON:

All right.

472 (Discussion held off the record between Defense counsel.)
473 MR. THOMPSON:

When you applied for this grant from the Department of Justice, were you given any promises of access to data from the FBI that other scientists would not have?

474 DR. WEIR:

That is a two-part question. I was promised access to the FBI data. I know nothing about other people.

475 MR. THOMPSON:

Okay. And you are being compensated for your time on this case?

476 DR. WEIR:

No, I'm not. In fact, I'm losing money. The county is not paying enough for my meals each day.

477 MR. THOMPSON:

All right. So--so with regard to the work you did in preparing?

478 DR. WEIR:

With regard from the beginning to the end, there will be not one dollar comes to me.

479 MR. THOMPSON:

Okay.

480 DR. WEIR:

As I said, it is flowing the other way.

481 MR. THOMPSON:

I didn't hear you.

482 DR. WEIR:

The money is flowing the other direction.

483 MR. THOMPSON:

Flowing the other direction. I think that is very public-spirited of you, sir. One moment.

484 (Discussion held off the record between Defense counsel.)
485 MR. THOMPSON:

Okay. No further questions, your Honor.

486 THE COURT:

All right. Thank you, Dr. Weir.

Temperature

tense

Key Quotes (5)

Dr. Bruce Weir
That statement is correct, but it is misleading in the sense it gives us no basis for interpreting the evidentiary value of this mixed stain. It is a correct statement, but I don't think it has any relevance.
Weir concedes the Defense's 45% figure is scientifically correct while arguing it is meaningless — a distinction Thompson exploits to show both methods yield defensible numbers.
Dr. Bruce Weir
That statement you made, and I listened very carefully, I think comes very close to being dishonest.
Weir accuses Thompson of being nearly dishonest in how he framed the 45% figure, the sharpest moment of personal conflict in the proceeding.
Dr. Bruce Weir
I resent that completely. That is not just an argument. That is the only conceivable way of attaching a frequency to the match of two known contributors in a mixed stain.
Weir reacts with visible indignation when Thompson describes his statistical position as 'just an argument,' illustrating how personally invested the expert is in his methodology.
Lance A. Ito
It is a complete waste of my time so far, this whole discussion about bootstrapping.
Judge Ito openly expresses frustration, cutting off Thompson's 'bootstrapping' line of questioning entirely and revealing his skepticism of where the defense was heading.
Dr. Bruce Weir
My opinion has changed. I think if you had asked me two years ago, I would have agreed. We are now at the point that the numbers are beyond belief... I believe we have passed beyond the point where we should run around trying to make up numbers acceptable to everybody.
Weir admits his view on whether numbers are necessary for mixture statistics has evolved — an opening Thompson uses to undermine the consistency of his expert opinion.

Evidence (8)

Defense Chart 410
Defense-prepared chart summing genotype frequencies for mixture contributors per NRC method
discussed, contested
Prosecution Chart 409
Prosecution-prepared chart showing mixture frequency as product of two contributor genotype frequencies (.15%)
discussed, contrasted with Defense chart
Exhibit 408
Weir's report dated June 21st, containing 'Mixed stains' paragraph criticizing NRC approach
introduced, used to impeach Weir's current interpretation of NRC report
Informal
Item 29 — blood stain on the Bronco steering wheel with PCR results only, three alleles observed
discussed extensively as test case for competing mixture methodologies
Informal
Item 78 — stain on the bottom of Ronald Goldman's boot, containing alleles consistent with Nicole Brown Simpson and Goldman
discussed; Goldman has alleles not observed in stain, raising missing-allele assumption questions
Informal
Items 305 and other Bronco stains
referenced
+ 2 more

Notable Exchanges (5)

Mr. ThompsonDr. Bruce Weir
Thompson methodically walks Weir through the assumptions required by his method — number of contributors and completeness of observed alleles — and extracts admissions that the Defense's simpler NRC approach requires neither assumption. Weir repeatedly insists the assumptions are scientifically necessary regardless.
strategic
Mr. ThompsonDr. Bruce Weir
Thompson confronts Weir with three different reports produced in quick succession (May 11, May 31, June 20, June 21), noting changing positions on likelihood ratios and the NRC method. Weir concedes his June 20th report criticized the NRC in a way he now walks back.
revealing
Mr. ThompsonDr. Bruce Weir
On item 78, Thompson argues Weir assumed missing alleles at loci where Goldman did not match but made no such assumption where Goldman did match, making the analysis circular. Weir denies making any assumptions, attributing all premises to Cellmark's forensic determination.
heated
Mr. ThompsonLance A. Ito
Thompson attempts a 'bootstrapping' line of questioning suggesting Weir's choice of assumptions was influenced by the prosecution's theory. Judge Ito sustains objections multiple times, then cuts off the entire line, calling it 'a complete waste of my time.'
tense
Lance A. ItoMr. Thompson
After Thompson establishes uncertainty about whether item 29 has two or three contributors based on genetic evidence alone, Judge Ito volunteers that he is not deciding in a vacuum — he is considering there are two victims and only one set of footprints.
revealing

Light Moments (1)

Mr. Thompson
Thompson mistakenly says the Evett paper was published in 1990, then corrects himself; Weir had originally said 1991, which turns out to be right, and Thompson awkwardly admits 'I am reading wrong. You are right.'

Credibility Attacks (3)

⚔ Dr. Bruce Weir
prior inconsistent statement / shifting position
Thompson uses Weir's June 20th report, which sharply criticized the NRC mixture method as having 'no probative value,' against Weir's current, more nuanced position that the NRC language was merely 'loose.' Weir concedes the June 20th characterization was 'unfair to the NRC.'
⚔ Dr. Bruce Weir
bias / circular reasoning
Thompson argues Weir's item 78 analysis assumed missing alleles exactly where needed to avoid excluding Goldman, and nowhere else — implying the analysis was reverse-engineered to fit the prosecution's theory. Weir denies making any independent assumptions, deflecting entirely to Cellmark's determinations.
⚔ Dr. Bruce Weir
changing expert opinion
Thompson notes Weir produced multiple reports in rapid succession with evolving positions on likelihood ratios and whether numbers are even necessary for mixture evidence, suggesting his opinions are unstable or litigation-driven.

Witness Demeanor

Weir repeatedly interrupts or anticipates Thompson's questions before they finish
Weir grows visibly exasperated, saying 'I don't know how else I can say it, I'm sorry' and 'I have answered that several times'
Weir uses strong language unprompted: 'I think comes very close to being dishonest,' 'I resent that completely,' 'that is a foolish question'
(Discussion held off the record between Defense counsel) — multiple times, suggesting Thompson was consulting colleagues mid-cross

Objections

14 objections (7 sustained, 7 overruled)
Proceeding 6512 • 486 utterances • Prosecution witness
Criminal Trial
Department 103
⚖️ Start
📂 JUN 22, 1995 📄 Redirect examination of Dr. Br
JUN 22, 1995 KRT DvH TD